| Complement and coagulation: strangers or partners in crime? MM Markiewski, B Nilsson, KN Ekdahl, TE Mollnes, JD Lambris Trends in immunology 28 (4), 184-192, 2007 | 731 | 2007 |
| Essential role of the C5a receptor in E coli–induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation TE Mollnes, OL Brekke, M Fung, H Fure, D Christiansen, G Bergseth, ... Blood, The Journal of the American Society of Hematology 100 (5), 1869-1877, 2002 | 578 | 2002 |
| The role of complement in biomaterial-induced inflammation B Nilsson, KN Ekdahl, TE Mollnes, JD Lambris Molecular immunology 44 (1-3), 82-94, 2007 | 538 | 2007 |
| The alternative complement pathway revisited M Harboe, TE Mollnes Journal of cellular and molecular medicine 12 (4), 1074-1084, 2008 | 392 | 2008 |
| The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation M Harboe, G Ulvund, L Vien, M Fung, TE Mollnes Clinical & Experimental Immunology 138 (3), 439-446, 2004 | 391 | 2004 |
| Quantification of the terminal complement complex in human plasma by an enzyme‐linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex TE Mollnes, T Lea, SS Frøland, M Harboe Scandinavian journal of immunology 22 (2), 197-202, 1985 | 391 | 1985 |
| Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis A Castellheim, OL Brekke, T Espevik, M Harboe, TE Mollnes Scandinavian journal of immunology 69 (6), 479-491, 2009 | 353 | 2009 |
| Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA MA Seelen, A Roos, J Wieslander, TE Mollnes, AG Sjöholm, R Wurzner, ... Journal of immunological methods 296 (1-2), 187-198, 2005 | 346 | 2005 |
| Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, ... Proceedings of the National Academy of Sciences 117 (40), 25018-25025, 2020 | 340 | 2020 |
| Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations V Videm, JL Svennevig, E Fosse, G Semb, TE Mollnes, H Nielsen The Journal of thoracic and cardiovascular surgery 103 (4), 806-813, 1992 | 297 | 1992 |
| Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release EO Samstad, N Niyonzima, S Nymo, MH Aune, L Ryan, SS Bakke, ... The Journal of Immunology 192 (6), 2837-2845, 2014 | 292 | 2014 |
| Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study TML Eagan, T Ueland, PD Wagner, JA Hardie, TE Mollnes, JK Damås, ... European respiratory journal 35 (3), 540-548, 2010 | 259 | 2010 |
| Complement activation and endotoxin levels in systemic meningococcal disease P Brandtzaeg, TE Mollnes, P Kierulf Journal of Infectious Diseases 160 (1), 58-65, 1989 | 256 | 1989 |
| Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome M Trøseid, KT Lappegård, T Claudi, JK Damås, L Mørkrid, R Brendberg, ... European heart journal 25 (4), 349-355, 2004 | 253 | 2004 |
| Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. K Høgåsen, JH Jansen, TE Mollnes, J Hovdenes, M Harboe The Journal of clinical investigation 95 (3), 1054-1061, 1995 | 247 | 1995 |
| The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes H Husebye, MH Aune, J Stenvik, E Samstad, F Skjeldal, Ø Halaas, ... Immunity 33 (4), 583-596, 2010 | 245 | 2010 |
| Complement in inflammatory tissue damage and disease TE Mollnes, WC Song, JD Lambris Trends in immunology 23 (2), 61-64, 2002 | 225 | 2002 |
| Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma TE Mollnes, T Lea, M Harboe, J Tschopp Scandinavian journal of immunology 22 (2), 183-195, 1985 | 225 | 1985 |
| An international serum standard for application in assays to detect human complement activation products G Bergseth, JK Ludviksen, M Kirschfink, PC Giclas, B Nilsson, TE Mollnes Molecular immunology 56 (3), 232-239, 2013 | 220 | 2013 |
| Age and sex-associated changes of complement activity and complement levels in a healthy Caucasian population M Gaya da Costa, F Poppelaars, C Van Kooten, TE Mollnes, F Tedesco, ... Frontiers in immunology 9, 2664, 2018 | 217 | 2018 |
Peter GarredProfessor of Clinical Molecular Medicine, University of CopenhagenVerified email at post5.tele.dk
